AI Article Synopsis

  • Coagulase-negative staphylococci (CoNS), previously overlooked as contaminants, are increasingly recognized as significant causes of bloodstream infections, necessitating closer examination due to their rising antibiotic resistance.
  • A study analyzing nearly 15,000 CoNS isolates from blood cultures in the Northern Netherlands between 2013 and 2019 identified 27 species, revealing that a small number of species accounted for the majority of infections and varied significantly in their resistance profiles.
  • The findings suggest a need for revised treatment guidelines that account for the diversity and resistance patterns of CoNS, rather than treating them as a uniform group, to improve patient outcomes in clinical settings.

Article Abstract

Background: For years, coagulase-negative staphylococci (CoNS) were not considered a cause of bloodstream infections (BSIs) and were often regarded as contamination. However, the association of CoNS with nosocomial infections is increasingly recognized. The identification of more than 40 different CoNS species has been driven by the introduction of matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Yet, treatment guidelines consider CoNS as a whole group, despite increasing antibiotic resistance (ABR) in CoNS. This retrospective study provides an in-depth data analysis of CoNS isolates found in human blood culture isolates between 2013 and 2019 in the entire region of the Northern Netherlands.

Methods: In total, 10,796 patients were included that were hospitalized in one of the 15 hospitals in the region, leading to 14,992 CoNS isolates for (ABR) data analysis. CoNS accounted for 27.6% of all available 71,632 blood culture isolates. EUCAST Expert rules were applied to correct for errors in antibiotic test results.

Results: A total of 27 different CoNS species were found. Major differences were observed in occurrence and ABR profiles. The top five species covered 97.1% of all included isolates: , , , and . Regarding ABR, methicillin resistance was most frequently detected in (72%), (65%), and (62%). and showed 50-80% resistance to teicoplanin and macrolides while resistance to these agents remained lower than 10% in most other CoNS species.

Conclusion: These differences are often neglected in national guideline development, prompting a focus on 'ABR-safe' agents such as glycopeptides. In conclusion, this multi-year, full-region approach to extensively assess the trends in both the occurrence and phenotypic resistance of CoNS species could be used for evaluating treatment policies and understanding more about these important but still too often neglected pathogens.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506452PMC
http://dx.doi.org/10.3390/microorganisms10091801DOI Listing

Publication Analysis

Top Keywords

cons
12
cons species
12
trends occurrence
8
occurrence phenotypic
8
phenotypic resistance
8
coagulase-negative staphylococci
8
staphylococci cons
8
human blood
8
2013 2019
8
data analysis
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!